Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2014
05/21/2014CN103814029A 取代的咪唑并哒嗪 Substituted imidazopyridazine
05/21/2014CN103804391A 一类治疗神经退行性疾病的化合物及其用途 A class of compounds treatment of neurodegenerative diseases and their use
05/21/2014CN103804384A 苯并二氮杂卓类化合物的制备方法 Benzodiazepine class of compounds prepared
05/21/2014CN103804383A 作为syk-激酶抑制剂的吡咯并吡嗪 As syk- kinase inhibitors pyrrolopyrazine
05/21/2014CN103804382A 一类治疗湿疹的化合物及其用途 A class of compounds and their use to treat eczema
05/21/2014CN103804381A 一类治疗缺血性脑损伤的化合物及其用途 A class of therapeutic compounds ischemic brain injury and their use
05/21/2014CN103804365A 一类治疗接触性皮炎的化合物及其用途 A class of therapeutic compounds contact dermatitis and their use
05/21/2014CN103804317A 一类治疗精神分裂症的化合物及其用途 A class of compounds and their use in treatment of schizophrenia
05/21/2014CN103804307A 一类治疗缺血性脑损伤的化合物及其用途 A class of therapeutic compounds ischemic brain injury and their use
05/21/2014CN103800333A 火木层孔菌中环二肽c8在抗禽流感h5n1病毒上的应用 Fire Phellinus Central dipeptide c8 application in anti-bird flu h5n1 virus
05/21/2014CN103800332A 火木层孔菌中环二肽c6在抗禽流感h5n1病毒上的应用 Fire Phellinus Central dipeptide c6 applications in anti-bird flu h5n1 virus
05/21/2014CN103800331A 火木层孔菌中环二肽c7在抗禽流感h5n1病毒上的应用 Fire Phellinus Central dipeptide c7 applications in anti-bird flu h5n1 virus
05/21/2014CN103800330A 火木层孔菌中环二肽c5在抗禽流感h5n1病毒上的应用 Fire Phellinus Central dipeptide c5 application in the anti-bird flu h5n1 virus on
05/21/2014CN103800329A 火木层孔菌中环二肽c1在抗禽流感h5n1病毒上的应用 Fire Phellinus Central dipeptide c1 application in anti-bird flu h5n1 virus
05/21/2014CN101903387B 8-苯氨基咪唑并吡啶和它们在制备抗癌剂和/或抗炎剂中的用途 8-anilino-imidazopyridine and their use in the manufacture of an anticancer agent and / or anti-inflammatory agent
05/20/2014US8729264 Agent for prevention and/or treatment of skin diseases
05/20/2014US8729262 Reverse-turn mimetics and method relating thereto
05/20/2014US8729260 Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
05/20/2014US8729258 Luminescent macrocyclic lanthanide complexes
05/20/2014US8729257 Hybrid lipid compounds based on pentaerythritol, intermediates, preparation methods and use thereof
05/20/2014US8729096 Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators
05/20/2014US8729082 Substituted imidazoquinoxalines
05/20/2014US8729079 Pyrimido-pyridazinone compounds and methods of use thereof
05/20/2014US8729072 Alkylated piperazine compounds
05/20/2014US8729067 Pharmacological treatment of cognitive impairment
05/20/2014CA2624882C Pyrazolopyrimidines as protein kinase inhibitors
05/20/2014CA2621261C Azepine inhibitors of janus kinases
05/15/2014WO2014074906A1 Alternative uses for hbv assembly effectors
05/15/2014WO2014074665A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis
05/15/2014WO2014074657A1 Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
05/15/2014WO2014073989A1 Salt and polymorphic forms of (3r,4s)-l-((4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(mtdia)
05/15/2014WO2014072435A1 Substituted tricyclic benzimidazoles as kinase inhibitors
05/15/2014WO2014072261A1 Triazolo compounds
05/15/2014WO2014071824A1 4-quinazolinamine heterocyclic compound and use thereof
05/15/2014US20140135347 Inhibitors of bruton's tyrosine kinase
05/15/2014US20140135336 Triazolopyridazine
05/15/2014US20140135335 Spiro bicyclic oxalamide compounds for the treatment of hepatitis c
05/15/2014US20140135323 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals
05/15/2014US20140135319 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
05/15/2014US20140135316 Bromodomain inhibitors and uses thereof
05/15/2014US20140135312 Pyrrolopyrimidine compounds and their uses
05/15/2014US20140135311 Tetrahydro-pyrimidoazepines as modulators of trpv1
05/15/2014US20140134133 Heteroaromatic compounds as pi3 kinase modulators and methods of use
05/15/2014US20140134130 Fused bicyclic oxalamide compounds for the treatment of hepatitis c
05/14/2014EP2729468A2 Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
05/14/2014EP2729467A1 Cryptate compounds
05/14/2014EP2729466A1 Novel pyrrolo pyrimidine derivatives
05/14/2014EP2729448A1 Compounds for the treatment of hiv
05/14/2014CN203593712U 叶绿素金属盐制备设备 Chlorophyll metal preparation equipment
05/14/2014CN203593711U 叶绿素提取生产设备 Chlorophyll Extraction Equipment
05/14/2014CN1918162B 新的稠合吡咯并咔唑类化合物 New pyrrolocarbazole fused compounds
05/14/2014CN103797024A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
05/14/2014CN103797014A 新有机电致发光化合物和使用该化合物的有机电致发光器件 The new organic electroluminescent compounds and the use of the compounds are organic electroluminescent devices
05/14/2014CN103797013A 吡唑并[3,4-d]嘧啶化合物、它们的制备及作为西格玛配体的用途 Pyrazolo [3,4-d] pyrimidine compounds, their preparation and use, as the sigma ligands
05/14/2014CN103797010A 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物 As jak inhibitor azetidin alkylphenyl, pyridyl or pyrazinyl carboxamide derivatives
05/14/2014CN103797006A 用作端锚聚合酶抑制剂的4-哌啶基化合物 Used tankyrase inhibitors 4- piperidinyl compound
05/14/2014CN103788940A 聚集诱导发光荧光分子及其制备方法和荧光染料组合物以及它们在线粒体染色中的应用 AIE fluorescent molecule and its preparation method and fluorescent dye compositions and their use in the mitochondria Dyeing
05/14/2014CN103788101A 交联金属卟啉纳米晶及其制备方法和光探测器的制作方法 Crosslinking method of making nanocrystalline metal porphyrin and its preparation method and an optical detector
05/14/2014CN103788100A 作为cdk抑制剂的吡咯并嘧啶化合物 As cdk inhibitors pyrrolo pyrimidine compounds
05/14/2014CN103788099A 利用环状硫脲生产双环胍的方法 Thiourea produced by the ring bicyclic guanidine method
05/14/2014CN103788098A 作为jak抑制剂的氮杂环丁烷和环丁烷衍生物 As jak inhibitor azetidine and cyclobutane derivatives
05/14/2014CN103788097A 稠环化合物和其用途 Fused ring compounds and their use
05/14/2014CN103788089A 作为血清素受体调节剂的稠合杂环化合物 As serotonin receptor modulators fused heterocyclic compounds
05/14/2014CN103784458A 新型苯基丙氨酸衍生物 The new phenylalanine derivatives
05/14/2014CN103784454A 一种含有培美曲塞二钠化合物的药物组合物 A pharmaceutical composition containing a culture pemetrexed disodium compound
05/14/2014CN102471346B Jak的三环抑制剂 Jak tricyclic inhibitors
05/14/2014CN102167704B 水溶性卟啉金（Ⅲ）抗癌化合物及其制备方法 Water-soluble porphyrin Gold (Ⅲ) anticancer compounds and methods
05/14/2014CN102066370B 苯基-咪唑并吡啶类和哒嗪类 Phenyl - Imidazopyridines and pyridazine
05/14/2014CN101475755B 氟化染料或着色剂以及它们的应用 Fluorinated dyes or colorants and their applications
05/13/2014US8722879 Redox-active structures and devices utilizing the same
05/13/2014US8722708 Substituted isoindolines as aspartyl protease inhibitors
05/13/2014US8722702 Compounds modulating c-fms and/or c-kit activity and uses therefor
05/13/2014US8722693 Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
05/13/2014US8722692 Compounds and compositions as Syk kinase inhibitors
05/13/2014US8722691 Azolopyrimidines as inhibitors of cannabinoid 1 activity
05/13/2014US8722676 Bicyclic piperazine compounds
05/13/2014US8722670 Selective NR2B antagonists
05/13/2014US8722665 Cinnamido-pyrrolo[2,1-C][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof
05/13/2014US8722661 Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
05/13/2014CA2647208C Glucokinase activators
05/13/2014CA2643668C Salt of cd 80 antagonist
05/13/2014CA2625207C Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
05/13/2014CA2623721C Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
05/13/2014CA2618524C Pyrazole derivatives having tyrosine kinase activity
05/13/2014CA2617095C Macrocylic inhibitors of hepatitis c virus
05/13/2014CA2601628C Certain substituted amides, method of making, and method of use thereof
05/13/2014CA2588760C Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives
05/08/2014WO2014071007A1 Hepatitis c virus inhibitors
05/08/2014WO2014070976A1 Inhibitors of cytomegalovirus
05/08/2014WO2014070774A1 Methods of generating beta-lactamase resistant carbapenem compounds
05/08/2014WO2014070029A1 Strongly fluorescent heterocycles and a method for their synthesis
05/08/2014WO2014069637A1 Organic electroluminescent element, lighting device and display device
05/08/2014WO2014069626A1 Method for producing pyrimidodiazepinone compound
05/08/2014WO2014069351A1 Method for producing optically active bicyclic urea compound
05/08/2014WO2014068341A2 Chiral fluorinating reagents
05/08/2014WO2014068256A1 Method for synthesising hexanitrohexaazaisowurtzitane from hexaallylhexaazaisowurtzitane; intermediates
05/08/2014WO2014042433A3 Compounds and compositions for modulating adenosine a3 receptor activity
05/08/2014WO2013062670A3 New routes to trans a,b-substituted bacteriochlorins
05/08/2014WO2013006808A3 Clavulanic acid for treatment of restless legs syndrome
05/08/2014WO2013006526A3 Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 573